In patients with Alzheimer's disease, impairment in TGF-β1 signaling is characterized by a reduction of TGF-β1 plasma levels and decreased receptor expression in neurons (85). The gene discussed is TGFB1; the disease is early-onset autosomal dominant Alzheimer disease.